Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy

Asthma is a chronic heterogeneous inflammatory airway disease affecting millions worldwide and remains a major global health burden. Despite advances in pharmacological therapy, a substantial proportion of patients continue to experience uncontrolled symptoms due to persistent airway inflammation and disease heterogeneity.

NCT Number	NCT07694947
Lead Sponsor	Mansoura University Hospital
Conditions	Allergic Asthma
Enrollment	100 participants
Start Date	2023-01-01
Primary Completion	2023-07-01 (estimated)
Study Completion	2024-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-10